The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
Research Funding - Pfizer
A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
 
Marcos J.G. De Lima
Consulting or Advisory Role - Celgene; Incyte; Pfizer; Pharmacyclics
Research Funding - Celgene; Pfizer
 
Partow Kebriaei
Honoraria - Kite, a Gilead company; Novartis; Pfizer
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Amgen; ZIOPHARM Oncology
Travel, Accommodations, Expenses - Kite, a Gilead company; Novartis; Pfizer
 
Francesco Lanza
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen
Research Funding - Pfizer
 
Christina Cho
Consulting or Advisory Role - AlloVir
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Gizelle Popradi
Honoraria - Abbvie; Kite, a Gilead Company; Kyowa Kirin; Merck; Novartis; Pfizer; Seagen; SERVIER; Taiho Oncology
Consulting or Advisory Role - Abbvie; Kite, a Gilead Company; Kyowa Kirin; Merck; Novartis; Pfizer; Seagen; SERVIER; Taiho Oncology
Speakers' Bureau - Abbvie; Gilead Sciences; Jazz Pharmaceuticals; Merck; Novartis; PeerVoice; Pfizer; Seagen; SERVIER
Research Funding - Jazz Pharmaceuticals; Novartis
 
Michael T Hemmer
Consulting or Advisory Role - Pfizer
 
Xin Zhang
Employment - Pfizer
 
Richa Shah
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Verna L. Welch
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Matthias Stelljes
No Relationships to Disclose
 
David I. Marks
Honoraria - Amgen; Kite, a Gilead Company; Novartis; Pfizer
Consulting or Advisory Role - Kite, a Gilead Company; Pfizer
Speakers' Bureau - Kite, a Gilead Company; Novartis; Pfizer
 
Wael Saber
No Relationships to Disclose